John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare. “The market” was terrified when Warren Buffett, Jamie Dimon and Jeff Bezos got together to disrupt healthcare three… Read More »Haven: The strategy that didn’t fix healthcare
Haven was a high-profile effort whereby three industry titans–Amazon, Berkshire Hathaway and JP Morgan–created a joint venture with the hope of lower costs and improving quality. Today, Haven announced it is shutting down in February. What happened? I don’t know the answer, but below are… Read More »A Haven No More
The joint effort by Amazon, Berkshire Hathaway and JPMorgan Chase to lower costs and provide better healthcare for their employees, will dissolve in February.
Shots: The 4 pivotal HAVEN studies (HAVEN-1, 2, 3, 4) included pooled data from 401 people with hemophilia A with/ out factor VIII inhibitors, with a median duration efficacy period of 120.4wks. Hemlibra maintained low treated bleed rates with ABR remaining low throughout the evaluation… Read More »Roche Presents Results of Hemlibra Reinforcing the Long-Term Benefits for Hemophilia A at ASH 2020
The company, a facilitator of patient-clinician communication, plans to use the funds to bring new features and capabilities to market, as well as build strategic partnerships. It has also added Dr. Dana Gelb Safran as senior vice president of value-based care and population health.
Amazon is testing a pilot to offer primary care clinics for its employees. The company plans to open 20 locations operated by direct primary care startup Crossover Health.